To advance St.Louis’ regional prosperity by cultivating a thriving biosciences sector. BioGenerator pursues this mission by building and investing in a robust pipeline of successful bioscience companies and entrepreneurs.
October 29, 2002
The “St. Louis Life Sciences Development Center” is incorporated by the Coalition for Plant and Life Sciences (later renamed BioSTL), as part of a comprehensive regional strategy for strengthening St. Louis’ bioscience innovation and entrepreneurship ecosystem. The Coalition for Plant and Life Sciences, founded and led by Dr. William Danforth, Chancellor Emeritus of Washington University in St. Louis, is comprised of the region’s top university, business, civic and philanthropic leaders, committed to establishing the infrastructure to capitalize on St. Louis’ unique strengths in medical and plant biosciences.
St. Louis Life Sciences Development Center renamed “BioGenerator.”
BioGenerator moves to CIC@CET.
BioGenerator hires new leadership team of Eric Gulve, President, Dan Broderick and Charlie Bolten, Vice Presidents
Launch of Pre-Seed Fund.
BioGenerator launches the BioGenerator Labs in the Cortex-1 building.
BioGenerator secures 1 of 6 national Challenge awards from U.S. Dept. of Commerce, the National Institutes of Health, and the National Science Foundation designed to reward the most innovative ideas to drive technology commercialization and entrepreneurship in regions. BioGenerator led execution of the program, which launched 13 new companies.
BioGenerator’s founding organization, the Coalition for Plant and Life Sciences, is reorganized under the name “BioSTL.” Multi-year financial commitments to BioSTL are announced by Washington University in St. Louis, BJC HealthCare, and St. Louis Life Science Project (an entity supported by St. Louis philanthropists Dr. William Danforth and John McDonnell).
BioGenerator expands its Entrepreneur in Residence (EIR) program with an award from the U.S. Dept. of Commerce’s Jobs & Innovation Accelerator Challenge.
BioGenerator reorganized as subsidiary of BioSTL, its funding organization.
Galera Therapeutics, previously launched with seed funding by BioGenerator, announces $11 million Series A financing.
BioGenerator portfolio companies cross the $100 million mark in additional, private investments attracted.
BioGenerator investment moves Agtech startup Benson Hill to St. Louis.
Launch of Post-Seed Fund.
BioGenerator investment moves Adarza BioSystems to St. Louis.
BioGenerator expands Labs facility to triple its size.
BioGenerator completes its 50th investment.
BioGenerator portfolio company Kogent Surgical announces Worldwide Distribution Agreement with Medtronic Surgical Technologies.
BioGenerator launches Agtech startup Arvegenix with Pre-Seed funding.
BioGenerator portfolio companies cross the $300 million mark in additional, private investments attracted.
BioGenerator launches YourBevCo, a beverage device company.
Cardialen, previously launched with BioGenerator seed funding, announces Series A financing and clinical development plans
BioGenerator portfolio company Apse announces seed financing and appointment of new CEO.
BioGenerator leads initial funding round for Healthcare IT startup Epharmix.
MediBeacon, previously launched with BioGenerator seed funding, announces $22.4 million Series A financing.
BioGenerator portfolio company SynerZ Medical is acquired in a private transaction.
BioGenerator is among the first 17 recipients, out of 240 applicants, of a $500,000 grant from the 2014 Regional Innovation Strategies program to create the St. Louis Regional Bioscience Proof of Concept Center.
BioSTL Fundamentals and Grants2Business programs formalized; industry veteran Harry Arader hired to direct new programs.
BioGenerator portfolio companies cross the $400 million mark in additional, private investments attracted.
Tioma Therapeutics, previously launched with seed funding by BioGenerator and based on technology developed at Washington University in St. Louis, announces $86 million Series A financing.
Pulse Therapeutics, previously launched with BioGenerator seed funding, announces $10M financing.
With investment from BioGenerator, Agtech startup Edison Agrosciences moves to St. Louis.
Galera Therapeutics, previously launched with BioGenerator seed funding, announces $57 million Series B financing.
BioGenerator investment catalyzes newly formed Indalo Therapeutics.
BioGenerator launches new research tools company Canopy Biosciences.
Adarza BioSystems, previously recruited to St. Louis with a BioGenerator seed investment, announces $17M Series B financing.